Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Braze (BRZE) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Braze (BRZE) over the last 5 years, with Q4 2025 value amounting to $97.8 million.

  • Braze's Cash & Equivalents rose 5953.65% to $97.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $97.8 million, marking a year-over-year increase of 5953.65%. This contributed to the annual value of $83.1 million for FY2025, which is 2174.18% up from last year.
  • As of Q4 2025, Braze's Cash & Equivalents stood at $97.8 million, which was up 5953.65% from $81.0 million recorded in Q3 2025.
  • In the past 5 years, Braze's Cash & Equivalents ranged from a high of $478.9 million in Q1 2022 and a low of $28.5 million during Q1 2021
  • Its 5-year average for Cash & Equivalents is $103.7 million, with a median of $78.2 million in 2023.
  • In the last 5 years, Braze's Cash & Equivalents skyrocketed by 157995.02% in 2022 and then crashed by 8567.93% in 2023.
  • Over the past 5 years, Braze's Cash & Equivalents (Quarter) stood at $42.0 million in 2021, then rose by 8.13% to $45.4 million in 2022, then surged by 33.22% to $60.5 million in 2023, then rose by 1.39% to $61.3 million in 2024, then skyrocketed by 59.54% to $97.8 million in 2025.
  • Its Cash & Equivalents stands at $97.8 million for Q4 2025, versus $81.0 million for Q3 2025 and $231.5 million for Q2 2025.